Xenon Pharmaceuticals Inc

XENE

...

XENE: Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Show XENE Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of XENE by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by XENE's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on XENE's company Twitter account

WallStreetBets

Number of mentions of XENE in WallStreetBets Daily Discussion

XENE News

Recent insights relating to XENE

CNBC Recommendations

Recent picks made for XENE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in XENE

Corporate Flights

Flights by private jets registered to XENE